|
FR2224175B1
(pl)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
|
BR8007911A
(pt)
|
1979-12-06 |
1981-06-16 |
Glaxo Group Ltd |
Inalador aperfeicoado
|
|
US4885287A
(en)
*
|
1988-08-09 |
1989-12-05 |
University Of Kentucky Research Foundation |
Novel method of administering aspirin and dosage forms containing same
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
DE69229070T2
(de)
|
1991-02-09 |
1999-11-18 |
B.S.D. Bio Science Development Snc Di Omini C. & Zuccari G., Bussero |
Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation
|
|
EP0499142A3
(en)
|
1991-02-09 |
1993-05-05 |
Hoechst Aktiengesellschaft |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
|
|
US5256538A
(en)
|
1991-03-08 |
1993-10-26 |
Board Of Regents, The University Of Texas System |
Detection of early platelet activation and prediagnosis of thrombotic events
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
US5639441A
(en)
|
1992-03-06 |
1997-06-17 |
Board Of Regents Of University Of Colorado |
Methods for fine particle formation
|
|
US6098620A
(en)
*
|
1993-01-29 |
2000-08-08 |
Aradigm Corporation |
Device for aerosolizing narcotics
|
|
US20070117862A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
PT101450B
(pt)
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
KR19980703876A
(ko)
|
1995-04-14 |
1998-12-05 |
스티븐 엘. 허스트 |
분산성이 개선된 분말화된 약학적 조성물
|
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
NZ511568A
(en)
|
1998-11-12 |
2003-08-29 |
Frank G |
An inhalation system using lipids for the delivery of bioactive compounds
|
|
JP3739955B2
(ja)
|
1999-01-11 |
2006-01-25 |
株式会社日立製作所 |
吸入式投薬器
|
|
US6630169B1
(en)
|
1999-03-31 |
2003-10-07 |
Nektar Therapeutics |
Particulate delivery systems and methods of use
|
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
|
ATE271400T1
(de)
|
1999-10-12 |
2004-08-15 |
Shl Medical Ab |
Inhalateur
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
HUP0300491A2
(en)
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
US6998137B2
(en)
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
|
DE60120401T2
(de)
|
2000-06-12 |
2006-12-21 |
Teijin Ltd. |
Mehrfachdosierspender zur verabreichung eines pulverförmigen medikamentes
|
|
EP1177805A1
(en)
|
2000-07-31 |
2002-02-06 |
Maryland Financial Inc. |
Powder inhaler
|
|
FR2812545B1
(fr)
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
|
KR20030038690A
(ko)
|
2000-08-07 |
2003-05-16 |
인헤일 테라퓨틱 시스템즈 인크. |
응집이 최소화된, 흡입성 분무 건조 4-나선 다발 단백질분말
|
|
US20020025917A1
(en)
|
2000-08-28 |
2002-02-28 |
Edward Pappalardo |
Compartmentalized device to enable a process of liquefying and administering aspirin as a first aid to heart attack victims
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
JP2004516304A
(ja)
|
2000-12-22 |
2004-06-03 |
アスペン・エアロジエルズ・インコーポレーテツド |
エーロゲル粉末含有治療剤
|
|
JP4874482B2
(ja)
|
2000-12-25 |
2012-02-15 |
第一三共株式会社 |
アスピリンを含有する医薬組成物
|
|
EP1350511B1
(en)
|
2000-12-25 |
2008-09-10 |
Daiichi Sankyo Company, Limited |
Medicinal compositions containing aspirin
|
|
ATE255929T1
(de)
|
2001-03-05 |
2003-12-15 |
Ivo Pera |
Inhalationsvorrichtung zum dispergieren von in kapseln enthaltenen pulverförmigen medikamente durch den respirationstrakt
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
|
GB0129270D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Pharmaceutical combination
|
|
GB0129397D0
(en)
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
|
ITMI20020078A1
(it)
|
2002-01-16 |
2003-07-16 |
Fabrizio Niccolai |
Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
SE524990C2
(sv)
|
2002-04-12 |
2004-11-09 |
Microdrug Ag |
Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
CA2500065A1
(en)
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
|
GB0226105D0
(en)
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
|
US7516741B2
(en)
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
|
US7284553B2
(en)
|
2002-12-12 |
2007-10-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
US20040206350A1
(en)
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
|
US7669596B2
(en)
|
2002-12-31 |
2010-03-02 |
Novartis Pharma Ag |
Aerosolization apparatus with rotating capsule
|
|
US7878193B2
(en)
|
2003-01-14 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Capsule for taking an active substance which can be inhaled
|
|
JP2006522834A
(ja)
|
2003-04-09 |
2006-10-05 |
ワイス |
［２−（８，９−ジオキソ−２，６−ジアザビシクロ［５．２．０］ノナ−１（７）−エン−２−イル）アルキル］ホスホン酸および誘導体の鼻腔内投与用医薬組成物およびその使用法
|
|
EP1615689B1
(en)
|
2003-04-09 |
2016-02-03 |
Novartis AG |
Aerosolization apparatus with capsule puncture alignment guide
|
|
DK1610850T3
(da)
|
2003-04-09 |
2012-06-25 |
Novartis Ag |
Aerosolapparat med luftindløbsskærm
|
|
GB0312419D0
(en)
|
2003-05-30 |
2003-07-02 |
Boots Healthcare Int Ltd |
Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
|
|
WO2004112702A2
(en)
|
2003-06-13 |
2004-12-29 |
Advanced Inhalation Research, Inc. |
Low dose pharmaceutical powders for inhalation
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
BRPI0412735A
(pt)
|
2003-07-18 |
2006-09-26 |
Baxter Int |
métodos para a fabricação, uso e composição de partìculas esféricas pequenas preparadas mediante a separação de fase controlada
|
|
US20060257987A1
(en)
|
2003-08-20 |
2006-11-16 |
Gonzalez Valcarcel Isabel Cris |
Ppar modulators
|
|
EP1658060A2
(en)
|
2003-08-22 |
2006-05-24 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Methods of treating copd and pulmonary hypertension
|
|
WO2005039489A2
(en)
|
2003-09-24 |
2005-05-06 |
Polymerix Corporation |
Compositions and methods for the inhibition of bone growth and resorption
|
|
GB2407040B
(en)
|
2003-10-15 |
2007-09-19 |
Sheikh Arshad Saeed |
Anti-platelet aggregation compositions
|
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
|
WO2005041886A2
(en)
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
EP1722799A4
(en)
|
2004-02-05 |
2011-02-09 |
Etienne-Emile Baulieu |
TREATMENT OF PULMONARY ARTERIAL HYPERTENSION BY DHEA, ITS ANALOGUES OR DERIVATIVES
|
|
JP2007523197A
(ja)
|
2004-02-23 |
2007-08-16 |
プロレキシーズ ファーマシューティカルズ インコーポレイテッド |
ｐＨＳＰ２０様活性を有する非ペプチジル剤、およびその使用
|
|
HUE058227T2
(hu)
|
2004-04-23 |
2022-07-28 |
Cydex Pharmaceuticals Inc |
DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz
|
|
JP4054368B2
(ja)
|
2004-05-04 |
2008-02-27 |
ファイザー株式会社 |
置換メチルアリール又はヘテロアリールアミド化合物
|
|
US7968575B2
(en)
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
US7189750B2
(en)
|
2004-05-05 |
2007-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
|
|
RU2006143544A
(ru)
|
2004-05-10 |
2008-06-20 |
Нэстек Фармасьютикал Кампани Инк. (Us) |
Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
|
|
US7556035B2
(en)
|
2004-05-28 |
2009-07-07 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
|
WO2006017354A1
(en)
|
2004-07-13 |
2006-02-16 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
MX2007001561A
(es)
|
2004-08-04 |
2007-04-16 |
Schering Corp |
Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
|
|
EP1812015B1
(en)
|
2004-11-02 |
2012-01-04 |
The Board of Trustees of Leland Stanford Junior University |
Methods for inhibition of nkt cells
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
ITMI20050417A1
(it)
|
2005-03-15 |
2006-09-16 |
Medestea Res & Production S R L |
Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
NZ566281A
(en)
|
2005-07-27 |
2010-08-27 |
Mdrna Inc |
Tight junction modulating peptide comprising the amino acid seqeunce CNGRCGGKKKLKLLLKLL and combinations thereof with therapeutic agents
|
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
WO2007076295A2
(en)
|
2005-12-16 |
2007-07-05 |
University Of Kansas |
Nanoclusters for delivery of therapeutics
|
|
WO2007072503A2
(en)
|
2005-12-21 |
2007-06-28 |
Panacea Biotec Ltd. |
Combinations for managing inflammation and associated disorders
|
|
US7201929B1
(en)
*
|
2005-12-30 |
2007-04-10 |
Alan James Group, Llc. |
Aspirin formulation for cardiovascular health
|
|
KR20150001844A
(ko)
|
2006-01-24 |
2015-01-06 |
넥스바이오, 인코퍼레이티드 |
고분자 미소 구체들의 조제를 위한 기술
|
|
GB0602049D0
(en)
*
|
2006-02-01 |
2006-03-15 |
Trumeter Company Ltd |
Inhaler
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
PT103481B
(pt)
*
|
2006-05-16 |
2008-08-01 |
Hovione Farmaciencia S A |
Inalador de uso simples e método de inalação
|
|
US7806117B2
(en)
|
2006-06-07 |
2010-10-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Peroral powder delivery device
|
|
US8201555B2
(en)
|
2006-06-27 |
2012-06-19 |
Brintech International Limited |
Inhaler
|
|
CA2660519A1
(en)
|
2006-08-10 |
2008-02-21 |
Roy C. Levitt |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
|
GB0621957D0
(en)
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
|
NL1033047C2
(nl)
|
2006-12-13 |
2008-06-16 |
Pharmachemie Bv |
Capsule, gevuld met een medicijn, in het bijzonder een inhaleerbaar medicijn.
|
|
GB0625303D0
(en)
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
|
GB0700839D0
(en)
|
2007-01-17 |
2007-02-21 |
Braithwaite Philip |
Device
|
|
EP1964564A1
(en)
|
2007-04-19 |
2008-09-03 |
LAB International SRL |
Breakthrough Pain Management
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
EP2170958A1
(en)
|
2007-06-13 |
2010-04-07 |
Amgen Inc. |
Il-17 heteromeric receptor complex
|
|
EP2173380A4
(en)
|
2007-07-13 |
2011-08-31 |
Abbott Biotech Ltd |
METHOD AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa HEMMER
|
|
WO2009015286A2
(en)
|
2007-07-24 |
2009-01-29 |
Nexbio, Inc. |
Technology for the preparation of microparticles
|
|
US9358242B2
(en)
|
2007-08-30 |
2016-06-07 |
Prelief Inc. |
Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
|
|
CN101888867B
(zh)
|
2007-12-05 |
2013-05-15 |
诺瓦提斯公司 |
用于可雾化的药物制剂的容器
|
|
US20110142914A1
(en)
|
2007-12-06 |
2011-06-16 |
Cytotech Labs, Llc |
Inhalable compositions having enhanced bioavailability
|
|
AU2008345034A1
(en)
|
2007-12-27 |
2009-07-09 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
|
|
DE102008004386A1
(de)
|
2008-01-14 |
2009-07-23 |
Activaero Gmbh |
Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
|
|
RU2534527C2
(ru)
|
2008-01-15 |
2014-11-27 |
Юниверсите Де Страсбур |
Синтез лактонов резорциловой кислоты, используемых в качестве терапевтических агентов
|
|
CN104151428B
(zh)
|
2008-02-21 |
2017-07-14 |
麒麟-安姆根有限公司 |
Il‑17ra‑il‑17rb拮抗物及其用途
|
|
GB0803369D0
(en)
|
2008-02-25 |
2008-04-02 |
Helperby Therapeutics Ltd |
Biological materials and uses thereof
|
|
BRPI0910691A2
(pt)
|
2008-04-04 |
2018-03-27 |
Irm Llc |
compostos e composições como inibidores de itpkb
|
|
US20090257957A1
(en)
|
2008-04-15 |
2009-10-15 |
John Burnier |
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
|
|
EA019507B1
(ru)
|
2008-05-13 |
2014-04-30 |
Айрм Ллк |
Конденсированные азотсодержащие гетероциклы и содержащие их композиции в качестве ингибиторов киназы
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
ES2929343T3
(es)
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
WO2010009028A1
(en)
|
2008-07-15 |
2010-01-21 |
Schering Corporation |
Intranasal compositions comprising a decongestant and a corticosteroid
|
|
EP2321023B1
(en)
|
2008-07-18 |
2016-06-15 |
Prosonix Limited |
Process for improving crystallinity of fluticasone particles
|
|
WO2010011329A2
(en)
|
2008-07-23 |
2010-01-28 |
Map Pharmaceuticals, Inc. |
The delivery of powdered drug via inhalation
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
KR20110056516A
(ko)
|
2008-09-12 |
2011-05-30 |
크리티컬 파머수티컬스 리미티드 |
점막 또는 피부를 통한 치료제의 흡수 개선
|
|
MX357919B
(es)
|
2009-03-13 |
2018-07-25 |
Nucitec Sa De Cv |
Composición farmacéutica para el tratamiento de la hipercolesterolemia.
|
|
ES2625260T5
(es)
|
2009-03-26 |
2020-07-29 |
Pulmatrix Operating Co Inc |
Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares
|
|
WO2010117951A1
(en)
|
2009-04-06 |
2010-10-14 |
The Regents Of The University Of California |
Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
|
|
CA3025627C
(en)
|
2009-04-20 |
2021-08-31 |
Auspex Pharmaceuticals, Inc. |
Piperidine inhibitors of janus kinase 3
|
|
GB0908129D0
(en)
|
2009-05-12 |
2009-06-24 |
Innovata Ltd |
Composition
|
|
JP2012526726A
(ja)
|
2009-05-15 |
2012-11-01 |
株式会社新日本科学 |
薬物動態が改善された鼻腔内用薬学的組成物
|
|
WO2010135253A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhaler dose counters
|
|
BRPI1009072B1
(pt)
|
2009-05-18 |
2021-06-22 |
Adamis Pharmaceuticals Corporation |
Dispositivo para inalação de pó seco e dispositivo para armazenamento de pó seco
|
|
US20120125325A1
(en)
|
2009-06-01 |
2012-05-24 |
Robin Mark Bannister |
The use of amlexanox in the therapy of neutrophil-driven diseases
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
GB0918431D0
(en)
|
2009-10-21 |
2009-12-09 |
Prosonix Ltd |
Process for improving crystallinity
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
CN102958537B
(zh)
|
2010-04-07 |
2015-09-16 |
Abbvie公司 |
TNF-α结合蛋白
|
|
EP2611438B1
(en)
|
2010-08-30 |
2020-04-01 |
Pulmatrix Operating Company, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
|
WO2012061902A1
(en)
|
2010-11-12 |
2012-05-18 |
Monash University |
Micronised spray-dried particles comprising polymyxin
|
|
JP6050758B2
(ja)
|
2010-12-07 |
2016-12-21 |
レスピラ セラピューティクス インコーポレイテッドＲｅｓｐｉｒａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
乾燥粉末吸入器及びその作動方法
|
|
CN102058886A
(zh)
|
2010-12-20 |
2011-05-18 |
云南白药集团无锡药业有限公司 |
医用粉雾剂及其应用
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
GB201102237D0
(en)
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
EP2696888B1
(en)
|
2011-04-12 |
2018-12-05 |
Moerae Matrix, Inc., |
Compositions and methods for preventing or treating pulmonary fibrosis
|
|
AU2012271274B2
(en)
|
2011-06-17 |
2017-07-27 |
Berg Llc |
Inhalable pharmaceutical compositions
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
KR20140069091A
(ko)
|
2011-09-06 |
2014-06-09 |
베로나 파마 피엘씨 |
기침 및 기침으로 인한 발작 치료
|
|
DK2790758T3
(da)
|
2011-12-16 |
2017-11-20 |
Indosys Ltd |
Kassette til en lægemiddeldosis og tilførselsindretning
|
|
US20130196906A1
(en)
|
2012-01-31 |
2013-08-01 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
KR20200015828A
(ko)
|
2012-02-28 |
2020-02-12 |
아이슈티카 홀딩스 인코포레이티드. |
흡입용 약제학적 조성물
|
|
CN107596518B
(zh)
|
2012-02-29 |
2021-04-23 |
普马特里克斯营业公司 |
可吸入干粉剂
|
|
US9663511B2
(en)
|
2012-03-26 |
2017-05-30 |
Arroyo BioSciences, LLC |
Sphingosine 1-phosphate receptor antagonists
|
|
GB201205632D0
(en)
|
2012-03-30 |
2012-05-16 |
Vectura Ltd |
Method and apparatus
|
|
KR20150006869A
(ko)
|
2012-05-03 |
2015-01-19 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
SG11201407676VA
(en)
|
2012-05-21 |
2015-03-30 |
Agency Science Tech & Res |
A dry powder formulation
|
|
WO2013188979A1
(en)
|
2012-06-20 |
2013-12-27 |
Frank Gu |
Mucoadhesive nanoparticle delivery system
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
US20150224129A1
(en)
|
2012-10-03 |
2015-08-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
|
|
EP2916836A4
(en)
|
2012-11-07 |
2016-08-03 |
Merck Sharp & Dohme |
AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
DK2948148T3
(da)
|
2013-01-28 |
2020-10-26 |
Incozen Therapeutics Pvt Ltd |
Metoder til behandling af autoimmune, åndedræts- og betændelsesforstyrrelser ved inhalation af roflumilast n-oxid
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
GB201305813D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
Compositions and methods
|
|
CA2910766C
(en)
|
2013-04-30 |
2020-12-15 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
|
JP2016534976A
(ja)
|
2013-05-23 |
2016-11-10 |
アズセラピーズ インコーポレイテッド |
クロモリンを送達する方法
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
|
|
EP3054937B1
(en)
|
2013-10-11 |
2023-07-26 |
Pulmokine, Inc. |
Spray dry formulations
|
|
EP3107935B1
(en)
|
2014-02-20 |
2020-06-24 |
Allergan, Inc. |
Complement component c5 antibodies
|
|
CN112656780A
(zh)
|
2014-02-20 |
2021-04-16 |
奥迪托皮克股份有限公司 |
用于吸入的干粉制剂
|
|
SG11201606983SA
(en)
|
2014-02-27 |
2016-09-29 |
Allergan Inc |
COMPLEMENT FACTOR Bb ANTIBODIES
|
|
US10344037B2
(en)
|
2014-03-26 |
2019-07-09 |
Canget BioTek Pharma LLC |
Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease
|
|
EP3126004A4
(en)
|
2014-04-02 |
2017-11-29 |
Rogne Bioscience Inc. |
Methods and compositions for treating inflammatory disorders
|
|
WO2015155544A1
(en)
|
2014-04-10 |
2015-10-15 |
Patrick Crowley |
Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
|